Structural and functional consequences of methionine oxidation in thrombomodulin.
暂无分享,去创建一个
[1] E. Komives,et al. NMR structures reveal how oxidation inactivates thrombomodulin. , 2003, Biochemistry.
[2] G. Davı̀,et al. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus , 2003, Journal of thrombosis and haemostasis : JTH.
[3] K. Okajima. Regulation of inflammatory responses by natural anticoagulants , 2001, Immunological Reviews.
[4] Weiqi Wang,et al. Elements of the Primary Structure of Thrombomodulin Required for Efficient Thrombin-activable Fibrinolysis Inhibitor Activation* , 2000, The Journal of Biological Chemistry.
[5] Robert Huber,et al. Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex , 2000, Nature.
[6] Elizabeth A. Komives,et al. Solution structure of the smallest cofactor-active fragment of thrombomodulin , 2000, Nature Structural Biology.
[7] D. Cowburn,et al. Direct determination of changes of interdomain orientation on ligation: use of the orientational dependence of 15N NMR relaxation in Abl SH(32). , 1999, Biochemistry.
[8] T. Squier,et al. Progressive decline in the ability of calmodulin isolated from aged brain to activate the plasma membrane Ca-ATPase. , 1998, Biochemistry.
[9] E. Komives,et al. Structure of the fifth EGF-like domain of thrombomodulin: An EGF-like domain with a novel disulfide-bonding pattern. , 1997, Journal of molecular biology.
[10] M. Churchill,et al. Oxidation of a critical methionine modulates DNA binding of the Drosophila melanogaster high mobility group protein, HMG‐D , 1997, FEBS letters.
[11] E. Komives,et al. The fifth epidermal growth factor-like domain of thrombomodulin does not have an epidermal growth factor-like disulfide bonding pattern. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] E. Komives,et al. Large-scale expression, purification and characterization of small fragments of thrombomodulin: the roles of the sixth domain and of methionine 388. , 1995, Protein engineering.
[13] E. Komives,et al. Thrombin‐binding affinities of different disulfide‐bonded isomers of the fifth EGF‐like domain of thrombomodulin , 1995, Protein science : a publication of the Protein Society.
[14] E. Komives,et al. Synthesis, activity, and preliminary structure of the fourth EGF‐like domain of thrombomodulin , 1995, Protein science : a publication of the Protein Society.
[15] E. Blasko,et al. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. , 1993, The Journal of biological chemistry.
[16] J. Parkinson,et al. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. , 1993, The Journal of biological chemistry.
[17] J. Lin,et al. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. , 1992, The Journal of clinical investigation.
[18] E. Conway,et al. Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. , 1992, Blood.
[19] C. Esmon,et al. The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.
[20] J. Hoidal,et al. Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Johnson,et al. The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. , 1979, The Journal of biological chemistry.
[22] D. Koshland,et al. A change in specificity of chymotrypsin caused by chemical modification of methionine residues. , 1966, The Journal of biological chemistry.